Markets
S&P 500------DOW------NASDAQ------BTC------GOLD------S&P 500------DOW------NASDAQ------BTC------GOLD------
Back to Glossary
HealthcareGLOSSARY

What Is Health Insurance?

Risk pooling system where individuals pay premiums to insurers who cover medical costs, creating massive healthcare sector cash flows.

James Liu 3 min readUpdated Apr 7, 2026

Opening Hook


UnitedHealth Group (UNH) just posted $94.9 billion in revenue for 2023, making it larger than Goldman Sachs and Nike combined. That staggering figure represents the financial muscle of America's health insurance machine – a sector that touches every portfolio, whether you realize it or not. When Warren Buffett calls healthcare costs "the tapeworm of American economic competitiveness," he's talking about an industry that consumes 18% of U.S. GDP.


What It Actually Means


Health insurance is a financial contract where individuals pay regular premiums to insurance companies, who then cover medical expenses when they arise. Think of it like a massive poker game where everyone antes up monthly, and the house (insurer) pays out when someone gets dealt a bad hand (illness or injury). The technical definition involves risk pooling – spreading healthcare costs across large groups to make individual expenses predictable and manageable. Insurers collect premiums, invest that float (just like Berkshire Hathaway does), and pay claims while maintaining profit margins. The basic formula is: Premiums Collected + Investment Income - Claims Paid - Operating Expenses = Profit. Medical Loss Ratios (MLR) typically run 80-85%, meaning 80-85 cents of every premium dollar goes directly to medical care.


How It Works in Practice


Let's examine Anthem (now Elevance Health, ELV) with 46 million members. If average monthly premiums are $450 per member, that generates $24.8 billion in annual premium revenue. Here's the cash flow breakdown:

Premium revenue: $24.8 billion
Claims paid: $20.4 billion (82% MLR)
Administrative costs: $2.9 billion (12%)
Operating profit: $1.5 billion (6% margin)

The company also earns investment income on premium float – money collected but not yet paid out in claims. With $15 billion in cash and investments earning 4%, that's another $600 million annually. During COVID-19, we saw this dynamic play out dramatically. Humana (HUM) saw claims drop 15% in Q2 2020 as elective procedures were cancelled, causing their stock to surge 25% while hospitals like HCA Healthcare (HCA) got hammered.


Why Smart Investors Care


Institutional investors love health insurers for their predictable cash generation and defensive characteristics. These companies essentially run sophisticated actuarial businesses – they price risk, collect premiums upfront, and pay claims later. The best operators like UNH have built vertically integrated ecosystems, owning pharmacy benefits (OptumRx) and healthcare services (OptumHealth), creating multiple revenue streams and cost controls. During market volatility, healthcare stocks often outperform because demand for medical care is largely inelastic. However, the contrarian insight is that regulatory risk is enormous – a single Medicare for All proposal can wipe out 20% of sector value overnight, as we saw during the 2020 Democratic primaries.


Common Mistakes to Avoid


Ignoring regulatory risk: Elizabeth Warren's wealth tax proposal in 2019 sent health insurer stocks down 8% in one day, despite having nothing to do with their business fundamentals
Misunderstanding the ACA's MLR requirements: Investors often miss that insurers must rebate premiums if they don't hit minimum medical spending thresholds
Overlooking seasonality: Q1 claims are always highest due to deductible resets, making year-over-year comparisons tricky
Confusing growth metrics: Member growth doesn't always equal profit growth if you're adding lower-margin Medicaid members versus higher-margin commercial ones

The Bottom Line


Health insurance represents one of the largest, most regulated cash flow machines in the global economy, offering both defensive characteristics and political risk in equal measure. For investors, the key is understanding that you're essentially buying into a government-regulated utility that processes human mortality risk. The question isn't whether people will need healthcare – it's whether private insurers will continue managing that risk, or if government eventually takes over the game entirely.